Interventional Radiology Products Market Expanding With Emerging Applications Worth $8.02 Billion.

 




Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology).

Market Growth and Key Factors Driving Revenue Growth:

The global interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%.

Market Revenue Growth Drivers:

1. Rising Prevalence and Incidence of Chronic Diseases
2. Growing Geriatric Population
3. Increasing Demand for Minimally Invasive Procedures

Download PDF Brochure:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=67681703

Detailed Market Segmentation Analysis:

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries.

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of this market segment are the increasing incidence of cancer and rising demand for minimally invasive procedures.

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=67681703 

Key Players:

Key players in the interventional radiology products market include Abbott Vascular (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Cardinal Health (U.S.), B. Braun Melsungen AG (Germany), C.R Bard (U.S.), Biosensor International Group Ltd. (Singapore), Stryker Corporation (U.S.), Terumo Corporation (Japan), and Cook Medical Inc. (U.S.).

Comments

Post a Comment

Popular posts from this blog

Metagenomic Sequencing Market: Major Revenue Surge is Expected in Shotgun Metagenomic Sequencing Technique

Image
What This Report Will Provide? This study involved four major activities in estimating the current size of the metagenomic sequencing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: [149 Pages Report] The metagenomic sequencing market is estimated to grow at a CAGR of 17.0% to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019. Major Growth Boosters: Market growth is largely driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from gover...
Read more

Healthcare Analytical Testing Services Market: Testing of Biologics & Biosimilars

Image
  In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of healthcare analytical testing services market. Market Revenue Growth Analysis: The healthcare analytical testing services market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4%. Market Segmentation Analysis: Within the type segment, the market is segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing services, microbial testing services, and environmental monitoring ...
Read more

Companion Diagnostics Market: Increasing Demand for Next-Generation Sequencing

Image
  What This Report Will Provide? This study involved four major activities in estimating the current size of the companion diagnostics market . Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: [333 Pages Report] The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9% Major Growth Boosters: Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer...
Read more